38 results
8-K
EX-99.3
GMDAQ
Gamida Cell Ltd
24 May 24
In the United States Bankruptcy Court for the District of Delaware
10:45am
, a “Solicitation Package”), which forms of Ballots were attached as Exhibit B-1 and Exhibit B-2 to the Scheduling Motion, to Holders of Claims entitled … . As described in the Voting Report and the Affidavits, the Debtor transmitted the Solicitation Package, the Combined Hearing Notice, the Notice of Non-Voting
8-K
GMDAQ
Gamida Cell Ltd
20 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:01pm
Officer. The votes were cast as follows:
Votes For
VotesAgainst
Abstained
CEO Compensation Package and Special Bonus
Broker Non-Votes: 19,950,804
8-K
EX-1.1
0t4kw9n
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
EX-99.1
upmcvvlib
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm
8-K
EX-10.1
n7uzxznom us
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-1.1
5f2 j0kl7bo1
30 Sep 22
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
4:02pm
DEF 14A
8jc6qb3mtbfj zt4ry
22 Jun 22
Definitive proxy
4:22pm
PRE 14A
d9ef 72tlmjucf4bta
10 Jun 22
Preliminary proxy
4:25pm
10-K
t7pulcntka763kyvt
24 Mar 22
Annual report
7:30am
6-K
EX-4.1
xnue9soq6jltzz7pv
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
6-K
EX-1.1
tu13p7
21 Dec 20
Gamida Cell Announces Pricing of $65 Million Public Offering of Ordinary Shares
4:38pm
6-K
EX-1.1
rosriw qy23rgdx7
20 May 20
Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares
4:14pm